N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(2-(tritylthio)ethyl)glycine, 95+%, 250mg

(R)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride, 95.0%, 10g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chlorophenyl)propanoic acid, 98%, 100mg

2-Amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine>98.0%(GC)(T)5g

N-(Cyclopropylmethyl)-N-methylamine, 97.0%, 1g

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 100mg

Diethanolamine, min. 99%, for synthesis, 10 l, plastic packaging.

Anthrarufin>85.0%(HPLC)25g

(2-Fluoro-6-(trifluoromethyl)phenyl)methanamine hydrochloride, 95.0%, 100mg

Filtration apparatus acc. to Witt, 150 mm, 45/40, 1 Piece

2-Naphthylacetonitrile>98.0%(GC)25g

Benzo[d]isoxazole-5-sulfonyl chloride, 95.0%, 5g

Disodium dihydrogenpyrophosphate, 95.0%, 25g